Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | STING1 | Q86WV6 | 20/20 | 0.55 |
| ▸ | TBK1 | Q9UHD2 | 1/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28414323 | 1.00 | STING1 (0.55) | STING1TBK1CYP3A4 | |
| SCHEMBL19451770 | 1.00 | STING1 (0.55) | STING1TBK1CYP3A4 | |
| SCHEMBL22150073 | 0.96 | STING1 (0.54) | STING1TBK1CYP3A4 | |
| SCHEMBL22408404 | 0.91 | STING1 (0.52) | STING1TBK1CYP3A4 | |
| SCHEMBL29689418 | 0.91 | STING1 (0.52) | STING1TBK1CYP3A4 | |
| SCHEMBL19451489 | 0.91 | STING1 (0.52) | STING1TBK1CYP3A4 | |
| SCHEMBL20066423 | 0.91 | STING1 (0.60) | STING1TBK1CYP3A4 | |
| SCHEMBL22428422 | 0.91 | STING1 (0.54) | STING1TBK1CYP3A4 | |
| SCHEMBL20876327 | 0.91 | STING1 (0.69) | STING1CYP3A4 | |
| SCHEMBL20876331 | 0.91 | STING1 (0.69) | STING1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4007758-B1 | BIS-[N-((5-CARBAMOYL)-1H-BENZO[D]IMIDAZOL-2-YL)-PYRAZOL-5-CARBOXAMIDE] DERIVATIVES AND RELATED COMPOUNDS AS STING (STIMULATOR OF INTERFERON GENES) AGONISTS FOR THE TREATMENT OF CANCER | MERSANA THERAPEUTICS INC (US) | 2026-05-13 | — | — | EP | disclosed |
| EP-4007758-A1 | BIS-[N-((5-CARBAMOYL)-1H-BENZO[D]IMIDAZOL-2-YL)-PYRAZOL-5-CARBOXAMIDE] DERIVATIVES AND RELATED COMPOUNDS AS STING (STIMULATOR OF INTERFERON GENES) AGONISTS FOR THE TREATMENT OF CANCER | Mersana Therapeutics, Inc. (US) | 2022-06-08 | — | — | EP | disclosed |